aTyr Pharma
LIFE
$1.90
Share price
2.70%
Change (1 day)
-9.95%
Change (1 year)
Categories
P/S ratio for aTyr Pharma (LIFE)
P/S ratio as of June 2024 (TTM): 223
According to aTyr Pharma's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 222.994. At the end of 2023 the company had a P/S ratio of 234.
P/S ratio history for aTyr Pharma from 2015 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 234 | 3723.94% |
| 2022 | 6.12 | |
| 2021 | N/A | -100% |
| 2020 | 4.09 | -89.37% |
| 2019 | 38.5 | |
| 2018 | N/A | |
| 2017 | N/A | |
| 2016 | N/A | |
| 2015 | N/A |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Vertex Pharmaceuticals VRTX | 12.0 | -94.62% | 🇺🇸 USA |
 Veracyte VCYT | 4.63 | -97.92% | 🇺🇸 USA |